Clicky

Seegene Inc(096530)

Description: Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of six SNPs in factor II, factor V, and MTHFR genes; BRAF mutation characteristic for papillary thyroid carcinoma from samples of thyroid tissue, fine needle aspiration biopsy, H&E slides, and paraffin-embedded tissues; Apolipoprotein E genotypes; and BCR/ABL fusion gene from blood and whole bone marrow. In addition, it offers PCR machines; vial cap management systems; nucleic acid extraction systems; automated liquid handling workstations from nucleic acid extraction to PCR setup; and real-time PCR detection systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.


Keywords: Natural Sciences Biotechnology Biology Infection Molecular Biology Molecular Diagnostics Respiratory Diseases Laboratory Techniques Tuberculosis Polymerase Chain Reaction Sepsis Detection Systems Meningitis Gastrointestinal Disease Amplifiers Real Time Polymerase Chain Reaction Ivd Respiratory Infections Molecular Diagnostics Products

Home Page: www.seegene.com

Taewon Building
Seoul, 05548
South Korea
Phone: 82 2 2240 4000


Officers

Name Title
Jong-Ki Kim Managing Director
Hak-Soo Lee VP
Dr. Jong-Yoon Chun Founder, CEO, CTO & Director
Jong-Gi Cheon VP and Chairman of Seegene Medical Foundation
Hae-Joon Park Managing Director
Mr. Jin-Soo Choi Exec. VP & Director
Mr. Byung-Kyun Ham Sr. Managing Director
Mr. Boo-Hyun Yang Sr. Managing Director
Dr. Richard S. Creager Ph.D. CEO of Seegene Technologies

Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 0.6505
IPO Date:
Fiscal Year End: December
Full Time Employees: 1008
Back to stocks